Insider Transactions in Q4 2024 at Amneal Pharmaceuticals, Inc. (AMRX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 22
2024
|
John Kiely Director |
SELL
Open market or private sale
|
Direct |
17,058
-6.0%
|
$136,464
$8.38 P/Share
|
|
Nov 22
2024
|
John Kiely Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,506
+9.11%
|
$114,024
$4.76 P/Share
|
|
Nov 22
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
33,229
-38.36%
|
$265,832
$8.34 P/Share
|
|
Nov 21
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
6,771
-7.25%
|
$54,168
$8.41 P/Share
|
|
Nov 21
2024
|
Jason B. Daly SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,665
-100.0%
|
$109,320
$8.4 P/Share
|
|
Nov 15
2024
|
Jason B. Daly SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
43,657
-76.16%
|
$349,256
$8.61 P/Share
|